Nuwellis Inc vs Solaredge Technologies Inc — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Solaredge Technologies Inc trades at $35.12 (market cap $2.17B). The key difference: Solaredge Technologies Inc is far larger — about 854.3× Nuwellis Inc's market cap, and Solaredge Technologies Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | SEDG | |
|---|---|---|
Market Cap | $2.54M | $2.17B |
Sector | Technology | Technology |
52-Week High | $164.50 | $78.51 |
52-Week Low | $0.73 | $28.47 |
Enterprise Value | -$1.17M | $2.03B |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
SolarEdge (SEDG) trades at $36.43, up 6.52% today, with a bullish technical signal despite negative profitability. Revenue declined to $1.18B in 2025, with a net loss of $405M, though recent quarterly EPS beat expectations. The stock shows improved cash flow from operations at $104M in 2025, and news highlights collaboration with Infineon for AI data center technology, driving positive sentiment.
Outlook remains cautious due to persistent losses and high debt, but analyst consensus price target of $41 offers 12.5% upside. Key risks include reliance on policy incentives and competitive pressures. Institutional sentiment is mixed with 23% buy ratings, suggesting patience for margin recovery and AI-related growth catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →